ONCOLOGY & PATIENT CARE

Oncology Care Experience & Support Survey

Capture how cancer patients and caregivers evaluate, navigate, and choose treatment support services, care coordination, and financial assistance programs, so you can sharpen patient acquisition, refine service positioning, and reduce care abandonment.

Pan-India sample
Cancer patients and caregivers (Active treatment or post-treatment)
15-20 min
Talk to a Survey Consultant
Care journey frictionIdentify where patients disengage, delay decisions, or switch providers mid-treatment.
Support program fit & gapsBenchmark which financial, emotional, and logistical support services convert enrollment.
TRUSTED BY LEADING BRANDS
Brand 0Brand 1Brand 2Brand 3Brand 4Brand 5Brand 6Brand 7Brand 8Brand 9Brand 10Brand 11Brand 12Brand 13Brand 14Brand 15Brand 16Brand 17Brand 18Brand 19Brand 20Brand 21Brand 22Brand 23Brand 24Brand 25Brand 26Brand 27Brand 28Brand 29Brand 30Brand 31

CONTEXT & RELEVANCE

Why run this survey now

Most oncology brands don't lose patients purely on clinical efficacy. They lose them due to fragmented care navigation, unmet emotional support needs, delayed specialist access, poor treatment side-effect communication, and misaligned caregiver involvement, none of which fully show up in prescription data or patient adherence trackers.

If you are...

  • Oncology patient support program lead
  • Pharma brand competing on care experience
  • Medical affairs or clinical outcomes head
  • Commercial lead, oncology portfolio
  • Patient engagement or access strategist

You're likely facing...

  • Care gap: diagnosis to treatment start
  • Support program drop-off mid-treatment
  • Oncologist vs patient priority mismatch
  • Caregiver burden: untracked, unaddressed
  • Brand switching at treatment line change

This will help answer...

  • Care experience drivers by tumor type
  • Support gap stage in treatment journey
  • Patient vs caregiver need segmentation
  • Unmet needs by line of therapy
  • Switching triggers at treatment transition

RESEARCH THEMES

What This Survey Investigates

Eight interconnected research themes that map the complete oncology patient journey from diagnosis to survivorship.

TENETS 01

Diagnosis & Navigation

  • Time from symptom to confirmed diagnosis
  • Referral pathways, specialist access
TENETS 02

Care Team Trust

  • Oncologist communication, shared decision-making
  • Multidisciplinary team coordination quality
TENETS 03

Treatment Experience

  • Infusion, radiation, surgical care touchpoints
  • Side effect management, protocol adherence
TENETS 04

Information & Education

  • Patient education materials, digital resources
  • Health literacy gaps across treatment stages
TENETS 05

Psychosocial Support

  • Mental health services, counselling access
  • Caregiver burden, family support gaps
TENETS 06

Financial Burden

  • Out-of-pocket costs, insurance coverage gaps
  • Financial toxicity, treatment decision trade-offs
TENETS 07

Care Coordination

  • Cross-facility handoffs, records continuity
  • Nurse navigator, patient portal utilisation
TENETS 08

Survivorship & Advocacy

  • Survivorship care plans, follow-up frequency
  • Peer advocacy, provider recommendation intent

SAMPLING STRATEGY

Tell us about your ideal sample

Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.

Sample size
How many respondents do you need?
Not Selected
Target audience
Who should we survey?
Not Selected
Region
Which regions should we cover?
Not Selected
Segments
How should we slice the data?
Not Selected
Discuss sample plan

METHODOLOGY

Survey approach

For the Oncology Care Experience & Support Survey, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification across patient, caregiver, and clinician segments.

PRIMARY
Online web surveySelf-administered survey shared via email / panels to capture structured responses at scale.
Best for
1
Measuring care satisfaction across treatment stages
2
Ranking support gaps by cancer type and line of therapy
3
Comparing patient and caregiver experience by care setting
Deliverables
Satisfaction driver ranking
Support gap matrix
Segment experience profiles
OPTIONAL
CATI (phone survey)Interviewer-led telephone interviews to reach owners who are harder to get online.
Best for
1
Older patients with limited digital access or comfort
2
Caregivers managing high treatment burden remotely
Deliverables
Representative patient coverage
Call-log diagnostics
SELECTIVE
Face-to-faceOn-ground surveys or interviews in key industrial clusters or high-value cohorts.
Best for
1
Advanced-stage patients requiring sensitive in-person engagement
2
Oncology nurses and coordinators at high-volume treatment centers
Deliverables
Clinic-level insights
Rich care journey maps
OPTIONAL
FGDs
Deliverables
Themes and verbatims
Concept feedback
OPTIONAL
Mixed surveysAny 4-mode combo Online + CATI + F2F + FGDs to maximise reach and representation. Mode-specific quotas and weighting for clean comparisons.
Deliverables
Unified dataset
Mode-adjusted analytics
Our Recommendation
Start with: Online web survey as the core quant layer, targeting patients, caregivers, and oncology nurses across active treatment and post-treatment cohorts.
Consider adding: CATI for older or low-digital patient segments, and F2F interviews at high-volume oncology centers where care experience nuance requires direct engagement.

EXECUTION PROCESS

How we execute

A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.

Define the decision frame

Confirm objectives, target cohorts, geographies, and reporting cuts

Step 01

Define the decision frame

Design the instrument

Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)

Step 02

Design the instrument

Lock the questionnaire

Review wording, sequencing, LOI, and competitive context; approve final version

Step 03

Lock the questionnaire

Pilot and calibrate

Test comprehension and ease quality; refine quotas and remove friction where needed

Step 04

Pilot and calibrate

Run fieldwork

Execute collection with active quota management and feasibility controls

Step 05

Run fieldwork

Assure quality

Dedupe, attention checks, speed/consistency rules, removals with audit trail

Step 06

Assure quality

Prepare the dataset

Clean data and deliver codebook/variable definitions

Step 07

Prepare the dataset

Analyse and synthesise

Driver ranking, leakage diagnostics, pricing bands, segment insights

Step 08

Analyse and synthesise

Deliver and align

Executive deck (optional dashboard) and leadership readout with recommendations

Step 09

Deliver and align

COMMERCIAL TERMS

Request a Commercial Proposal

Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.

Select Sample Size

100

Geography

  • India
  • APAC (Singapore, Vietnam, Philippines, Indonesia, Australia, NZ, Japan, Thailand)
  • Middle East (UAE, KSA, Qatar, Bahrain, Oman, Kuwait)
  • North America (US, Canada)
  • Europe
  • Africa (South Africa, Kenya, Nigeria, Egypt, Algeria)
  • LATAM (Brazil, Mexico)

Select Mode of Survey

  • Online
  • CATI
  • Online FGD (5 people per FGD)
  • F2F

Length of the Interview

  • Select
  • 0-15
  • 16-20
  • 21-30
  • 31-45
  • 46-60
  • Custom
Indicative Estimate
  • Indian Rupee (INR)
  • United Arab Emirates Dirham (AED)
  • Afghan Afghani (AFN)
  • Albanian Lek (ALL)
  • Armenian Dram (AMD)
  • Netherlands Antillean Guilder (ANG)
  • Angolan Kwanza (AOA)
  • Argentine Peso (ARS)
  • Australian Dollar (AUD)
  • Aruban Florin (AWG)
  • Azerbaijani Manat (AZN)
  • Bosnia-Herzegovina Convertible Mark (BAM)
  • Barbadian Dollar (BBD)
  • Bangladeshi Taka (BDT)
  • Bulgarian Lev (BGN)
  • Bahraini Dinar (BHD)
  • Burundian Franc (BIF)
  • Bermudian Dollar (BMD)
  • Brunei Dollar (BND)
  • Bolivian Boliviano (BOB)
  • Brazilian Real (BRL)
  • Bahamian Dollar (BSD)
  • Bhutanese Ngultrum (BTN)
  • Botswana Pula (BWP)
  • Belarusian Ruble (BYN)
  • Belize Dollar (BZD)
  • Canadian Dollar (CAD)
  • Congolese Franc (CDF)
  • Swiss Franc (CHF)
  • Chilean Peso (CLP)
  • Chinese Yuan (CNY)
  • Colombian Peso (COP)
  • Costa Rican Colón (CRC)
  • Cuban Peso (CUP)
  • Cape Verdean Escudo (CVE)
  • Czech Koruna (CZK)
  • Djiboutian Franc (DJF)
  • Danish Krone (DKK)
  • Dominican Peso (DOP)
  • Algerian Dinar (DZD)
  • Egyptian Pound (EGP)
  • Eritrean Nakfa (ERN)
  • Ethiopian Birr (ETB)
  • Euro (EUR)
  • Fijian Dollar (FJD)
  • Falkland Islands Pound (FKP)
  • British Pound (GBP)
  • Georgian Lari (GEL)
  • Ghanaian Cedi (GHS)
  • Gibraltar Pound (GIP)
  • Gambian Dalasi (GMD)
  • Guinean Franc (GNF)
  • Guatemalan Quetzal (GTQ)
  • Guyanese Dollar (GYD)
  • Hong Kong Dollar (HKD)
  • Honduran Lempira (HNL)
  • Croatian Kuna (HRK)
  • Haitian Gourde (HTG)
  • Hungarian Forint (HUF)
  • Indonesian Rupiah (IDR)
  • Israeli New Shekel (ILS)
  • Iraqi Dinar (IQD)
  • Iranian Rial (IRR)
  • Icelandic Króna (ISK)
  • Jamaican Dollar (JMD)
  • Jordanian Dinar (JOD)
  • Japanese Yen (JPY)
  • Kenyan Shilling (KES)
  • Kyrgyzstani Som (KGS)
  • Cambodian Riel (KHR)
  • Comorian Franc (KMF)
  • South Korean Won (KRW)
  • Kuwaiti Dinar (KWD)
  • Cayman Islands Dollar (KYD)
  • Kazakhstani Tenge (KZT)
  • Lao Kip (LAK)
  • Lebanese Pound (LBP)
  • Sri Lankan Rupee (LKR)
  • Liberian Dollar (LRD)
  • Lesotho Loti (LSL)
  • Libyan Dinar (LYD)
  • Moroccan Dirham (MAD)
  • Moldovan Leu (MDL)
  • Malagasy Ariary (MGA)
  • Macedonian Denar (MKD)
  • Burmese Kyat (MMK)
  • Mongolian Tögrög (MNT)
  • Macanese Pataca (MOP)
  • Mauritian Rupee (MUR)
  • Maldivian Rufiyaa (MVR)
  • Malawian Kwacha (MWK)
  • Mexican Peso (MXN)
  • Malaysian Ringgit (MYR)
  • Mozambican Metical (MZN)
  • Namibian Dollar (NAD)
  • Nigerian Naira (NGN)
  • Nicaraguan Córdoba (NIO)
  • Norwegian Krone (NOK)
  • Nepalese Rupee (NPR)
  • New Zealand Dollar (NZD)
  • Omani Rial (OMR)
  • Panamanian Balboa (PAB)
  • Peruvian Sol (PEN)
  • Papua New Guinean Kina (PGK)
  • Philippine Peso (PHP)
  • Pakistani Rupee (PKR)
  • Polish Złoty (PLN)
  • Paraguayan Guaraní (PYG)
  • Qatari Riyal (QAR)
  • Romanian Leu (RON)
  • Serbian Dinar (RSD)
  • Russian Ruble (RUB)
  • Rwandan Franc (RWF)
  • Saudi Riyal (SAR)
  • Solomon Islands Dollar (SBD)
  • Seychellois Rupee (SCR)
  • Sudanese Pound (SDG)
  • Swedish Krona (SEK)
  • Singapore Dollar (SGD)
  • Saint Helena Pound (SHP)
  • Sierra Leonean Leone (SLL)
  • Somali Shilling (SOS)
  • Surinamese Dollar (SRD)
  • São Tomé and Príncipe Dobra (STD)
  • Syrian Pound (SYP)
  • Swazi Lilangeni (SZL)
  • Thai Baht (THB)
  • Tajikistani Somoni (TJS)
  • Turkmenistani Manat (TMT)
  • Tunisian Dinar (TND)
  • Tongan Paʻanga (TOP)
  • Turkish Lira (TRY)
  • Trinidad and Tobago Dollar (TTD)
  • New Taiwan Dollar (TWD)
  • Tanzanian Shilling (TZS)
  • Ukrainian Hryvnia (UAH)
  • Ugandan Shilling (UGX)
  • United States Dollar (USD)
  • Uruguayan Peso (UYU)
  • Uzbekistani Som (UZS)
  • Vietnamese Đồng (VND)
  • Vanuatu Vatu (VUV)
  • Samoan Tālā (WST)
  • Central African CFA Franc (XAF)
  • East Caribbean Dollar (XCD)
  • West African CFA franc (XOF)
  • CFP Franc (XPF)
  • Yemeni Rial (YER)
  • South African Rand (ZAR)
  • Zambian Kwacha (ZMW)
  • Zimbabwean Dollar (ZWL)

$0.00

+ applicable taxes

Proposal turnaround typically 24–48 hours

Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.

REFERENCE CASELETS

Reference

Real-world examples of survey work in the oncology care and patient support space.

CASELET 1

Oncology patient support program gaps & channel preference (India)

CASELET 2

Oncologist-patient communication quality & unmet need (South Asia)

Oncology patient support program gaps & channel preference (India)

OBJECTIVE

A specialty pharma company needed to map how newly diagnosed patients and caregivers of late-stage patients engage with nurse navigator programs versus digital support portals , and where each channel loses them during active treatment.

WHAT WE DID

Ran a structured quant survey across 320 respondents in 6 metros, capturing program enrollment triggers, drop-off points, preferred contact frequency, and perceived emotional adequacy of each support format by cancer type and treatment stage.

DELIVERED

A channel preference map by patient archetype, a ranked friction list across 4 support program touchpoints, and a set of message territories to improve enrollment communication for newly diagnosed cohorts.
CASELET 1

Oncology patient support program gaps & channel preference (India)

CASELET 2

Oncologist-patient communication quality & unmet need (South Asia)

Oncology patient support program gaps & channel preference (India)

OBJECTIVE

A specialty pharma company needed to map how newly diagnosed patients and caregivers of late-stage patients engage with nurse navigator programs versus digital support portals , and where each channel loses them during active treatment.

WHAT WE DID

Ran a structured quant survey across 320 respondents in 6 metros, capturing program enrollment triggers, drop-off points, preferred contact frequency, and perceived emotional adequacy of each support format by cancer type and treatment stage.

DELIVERED

A channel preference map by patient archetype, a ranked friction list across 4 support program touchpoints, and a set of message territories to improve enrollment communication for newly diagnosed cohorts.

FREQUENTLY ASKED QUESTIONS

Common Questions

Answers to frequently asked questions about this survey mandate.

What decisions will this survey enable?

Who is the buyer vs who are the respondents?

Can we see differences between early-stage patients, late-stage patients and caregivers?

How will you measure treatment support preference beyond simple ratings?

Will the survey map the full oncology care journey and drop-offs?

Can this survey inform product and pricing strategy?

How will findings improve our patient support program enrollment and retention?

Still have questions?

Schedule a discovery call to discuss your specific needs and get a custom quote.

Book a Discovery Call